UX Research Intern, Click Therapeutics

Salary not provided

$22 an hr

New York

3-5 days a week in office

Click Therapeutics

Developing software as prescription treatments

Job no longer available

Click Therapeutics

Developing software as prescription treatments

101-200 employees

HealthcareB2CB2BSaaSBiotechnology

Job no longer available

Salary not provided

$22 an hr

New York

3-5 days a week in office

101-200 employees

HealthcareB2CB2BSaaSBiotechnology

Company mission

To deliver safe and effective digital treatments to patients in need.

Company mission

To deliver safe and effective digital treatments to patients in need.

18% employee growth in 12 months

Our take

Prescription medical treatments have historically been comprised only of pharmaceutical drugs and therapies, but digital therapeutics present an effective and low-cost alternative. With treatment provided through a clinically trialled app, these solutions have found success in tackling major medical issues such as type 2 diabetes, depression and smoking.

Click Therapeutics is one company working in this field, providing prescription software as a treatment for patients with unmet and high-burden needs such as chronic pain, major depressive disorder and migraines. There are many other companies working in this area, but its a rapidly growing market so there's plenty of room for competition.

Click Therapeutics is well-funded, leveraging capital to accelerate the development of its products and further improve the performance of its platform. And, as the efficacy of digital therapeutics becomes more widely-known, it is in a strong position to grow. FDA approval for its Rejoyn app, which helps treat major depressive disorder, is also a great step in the right direction.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Benefits

  • Annual performance-based cash bonus
  • Choice of Mac, Windows, or Linux equipment
  • Life insurance and disability benefits
  • Monthly catered lunches
  • Sponsored company events
  • Generous paid parental leave
  • Unlimited PTO
  • Stock options
  • Flexible Spending Accounts
  • 401(k) matching
  • Comprehensive medical benefits through Aetna
  • Open vacation policy
  • Commuter subsidies
  • Free, unlimited office snacks and beverages

Funding (last 2 of 9 rounds)

Oct 2021

$52m

SERIES B

Oct 2018

$19m

EARLY VC

Total funding: $96.6m

Leadership

David Benshoof Klein

(Founder & CEO)

Experience as Managing Director of Opus Point Partners from 2007 to 2012. Senior Consultant of Pfizer from 2012 to 2014.